Document is current

Suehara, Yasuhito

Sakamoto, Kana

Fujisawa, Manabu https://orcid.org/0009-0007-1122-6549

Fukumoto, Kota

Abe, Yoshiaki https://orcid.org/0000-0002-1021-7911

Makishima, Kenichi https://orcid.org/0000-0002-5808-816X

Suma, Sakurako

Sakamoto, Tatsuhiro https://orcid.org/0000-0001-6852-0721

Hattori, Keiichiro

Sugio, Takeshi

Kato, Koji

Akashi, Koichi https://orcid.org/0000-0001-7763-5723

Matsue, Kosei

Narita, Kentaro

Takeuchi, Kengo

Carreras, Joaquim https://orcid.org/0000-0002-6129-8299

Nakamura, Naoya

Chiba, Kenichi

Shiraishi, Yuichi

Miyano, Satoru https://orcid.org/0000-0002-1753-6616

Ogawa, Seishi

Chiba, Shigeru

Sakata-Yanagimoto, Mamiko https://orcid.org/0000-0001-7310-8045

Funding for this research was provided by:

MEXT | Japan Society for the Promotion of Science (JP21H02945)

MEXT | Japan Society for the Promotion of Science (JP19K23879)

MEXT | Japan Society for the Promotion of Science (JP21K16262)

MEXT | Japan Society for the Promotion of Science (JP20J20851)

MEXT | Japan Society for the Promotion of Science (JP23K15293)

MEXT | Japan Society for the Promotion of Science (JP23K15317)

MEXT | Japan Society for the Promotion of Science (JP21K16261)

MEXT | Japan Society for the Promotion of Science (JP23K15316)

Japan Agency for Medical Research and Development (JP22ck0106544)

Japan Agency for Medical Research and Development (JP23ck0106797)

Japan Agency for Medical Research and Development (JP23tk0124002)

Japan Agency for Medical Research and Development (JP24ck0106908)

MEXT | Japan Science and Technology Agency (JP22zf0127009)

Kobayashi Foundation for Cancer Research, Kobayashi Foundation, Chemo-Sero Therapeutic Research Institute, Takeda Science Foundation, and Uehara Memorial Foundation

Gilead Sciences

Leukemia and Lymphoma Society (3442-25)

Text and Data Mining valid from 2025-03-31

Version of Record valid from 2025-03-31